AbBaltis is heading to ADLM 2026.

Sourcing the right clinical samples should not be the bottleneck in research or assay development. Yet for many teams in IVD and biotech, securing well-characterised disease state plasma and serum, at the required volume and consistency, remains one of the biggest challenges.

Visit us at Booth #916 in Anaheim, July 28–30, to discuss specimen availability, custom sourcing requests, and how AbBaltis supports diagnostic and biomarker programmes worldwide.

If you would like to arrange a meeting in advance, contact us at sales@abbaltis.com.

📘 Explore our catalogue: https://lnkd.in/e99tHFTc

Our extensive portfolio includes infectious disease, allergy, autoimmune, cancer, and hormone markers.

We look forward to seeing you there.